• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚集效应和基于群体的动力学作为癌症治疗耐药性的一个来源

Aggregation Effects and Population-Based Dynamics as a Source of Therapy Resistance in Cancer.

作者信息

Brown Joel S, Cunningham Jessica J, Gatenby Robert A

出版信息

IEEE Trans Biomed Eng. 2017 Mar;64(3):512-518. doi: 10.1109/TBME.2016.2623564. Epub 2016 Nov 1.

DOI:10.1109/TBME.2016.2623564
PMID:28113286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5438296/
Abstract

OBJECTIVE

Evolution of resistance allows cancer cells to adapt and continue proliferating even when therapy is initially very effective. Most investigations of treatment resistance focus on the adaptive phenotypic properties of individual cells. We propose that the resistance of a single cell to therapy may extend beyond its own phenotypic and molecular properties and be influenced by the phenotypic properties of surrounding cells and variations in cell density. Similar variation exists in population densities of animals living in groups and can significantly affect the outcome of an external threat.

METHODS

We investigate aggregation effects in cancer therapy using Darwinian models that integrate phenotypic properties of individual cells and common population effects found in nature to simulate the dynamics of resistance and sensitivity in the diverse cellular environments within cancers.

RESULTS

We demonstrate that the density of cancer cell populations can profoundly influence response to chemotherapy independent of the properties of individual cells. Most commonly, these aggregation effects benefit the tumor allowing cells to survive even with phenotypic properties that would render them highly vulnerable to therapy in the absence of population effects.

CONCLUSION

We demonstrate aggregation effects likely play a significant role in conferring resistance to therapy on tumor cells that would otherwise be sensitive to treatment.

SIGNIFICANCE

The potential role of aggregation in outcomes from cancer therapy has not been previously investigated. Our results demonstrate these dynamics may play a key role in resistance to therapy and could be used to design evolutionarily-enlightened therapies that exploit aggregation effects to improve treatment outcomes.

摘要

目的

耐药性的演变使癌细胞能够适应并继续增殖,即使初始治疗非常有效。大多数关于治疗耐药性的研究都集中在单个细胞的适应性表型特性上。我们提出,单个细胞对治疗的耐药性可能超出其自身的表型和分子特性,并受到周围细胞的表型特性和细胞密度变化的影响。生活在群体中的动物种群密度也存在类似变化,并且会显著影响外部威胁的结果。

方法

我们使用达尔文模型研究癌症治疗中的聚集效应,该模型整合了单个细胞的表型特性和自然界中常见的种群效应,以模拟癌症中不同细胞环境下的耐药性和敏感性动态。

结果

我们证明癌细胞群体的密度可独立于单个细胞的特性而深刻影响对化疗的反应。最常见的是,这些聚集效应使肿瘤受益,即使细胞具有在没有种群效应时使其极易受到治疗影响的表型特性,也能使其存活。

结论

我们证明聚集效应可能在赋予原本对治疗敏感的肿瘤细胞治疗耐药性方面发挥重要作用。

意义

聚集在癌症治疗结果中的潜在作用此前尚未得到研究。我们的结果表明,这些动态可能在治疗耐药性中起关键作用,并可用于设计有进化启发的疗法,利用聚集效应来改善治疗结果。

相似文献

1
Aggregation Effects and Population-Based Dynamics as a Source of Therapy Resistance in Cancer.聚集效应和基于群体的动力学作为癌症治疗耐药性的一个来源
IEEE Trans Biomed Eng. 2017 Mar;64(3):512-518. doi: 10.1109/TBME.2016.2623564. Epub 2016 Nov 1.
2
Adaptive therapy.适应性疗法
Cancer Res. 2009 Jun 1;69(11):4894-903. doi: 10.1158/0008-5472.CAN-08-3658.
3
Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation.癌症中的细胞群体异质性与耐药性演变:生物学与数学评估、理论治疗优化
Biochim Biophys Acta. 2016 Nov;1860(11 Pt B):2627-45. doi: 10.1016/j.bbagen.2016.06.009. Epub 2016 Jun 20.
4
Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors.模拟空间结构和联合疗法对实体瘤表型异质性和耐药性的影响。
Bull Math Biol. 2015 Jan;77(1):1-22. doi: 10.1007/s11538-014-0046-4. Epub 2014 Dec 6.
5
Optimizing Cancer Treatment Using Game Theory: A Review.运用博弈论优化癌症治疗:综述。
JAMA Oncol. 2019 Jan 1;5(1):96-103. doi: 10.1001/jamaoncol.2018.3395.
6
Recurrence cancer stem cells--made by cell fusion?复发性癌症干细胞——由细胞融合产生?
Med Hypotheses. 2009 Oct;73(4):542-7. doi: 10.1016/j.mehy.2009.05.044. Epub 2009 Jun 28.
7
Compaction, fusion, and functional activation of three-dimensional human mesenchymal stem cell aggregate.三维人骨髓间充质干细胞聚集体的压实、融合及功能激活
Tissue Eng Part A. 2015 May;21(9-10):1705-19. doi: 10.1089/ten.TEA.2014.0314. Epub 2015 Mar 20.
8
A paradigm for therapy-induced microenvironmental changes in solid tumors leading to drug resistance.一种导致实体瘤产生耐药性的治疗诱导微环境变化的范例。
Differentiation. 2002 Dec;70(9-10):599-609. doi: 10.1046/j.1432-0436.2002.700913.x.
9
The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single nature.pH动态变化及Na+/H+反向转运体在癌症发病机制和治疗中的作用。同一硬币的两面——本质相同。
Biochim Biophys Acta. 2005 Sep 25;1756(1):1-24. doi: 10.1016/j.bbcan.2005.06.004.
10
Engineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumors.工程化细胞微环境响应型多肽纳米载体共包载小分子协同组合用于实体瘤的有效化疗。
Acta Biomater. 2017 Jan 15;48:131-143. doi: 10.1016/j.actbio.2016.10.034. Epub 2016 Oct 26.

引用本文的文献

1
Evolutionary rescue model informs strategies for driving cancer cell populations to extinction.进化救援模型为促使癌细胞群体灭绝的策略提供了依据。
bioRxiv. 2025 Jan 13:2024.11.26.625315. doi: 10.1101/2024.11.26.625315.
2
Spatial interactions modulate tumor growth and immune infiltration.空间相互作用调节肿瘤生长和免疫浸润。
NPJ Syst Biol Appl. 2024 Sep 30;10(1):106. doi: 10.1038/s41540-024-00438-1.
3
Spatial interactions modulate tumor growth and immune infiltration.空间相互作用调节肿瘤生长和免疫浸润。
Res Sq. 2024 May 22:rs.3.rs-3962451. doi: 10.21203/rs.3.rs-3962451/v1.
4
Spatial interactions modulate tumor growth and immune infiltration.空间相互作用调节肿瘤生长和免疫浸润。
bioRxiv. 2024 Mar 13:2024.01.10.575036. doi: 10.1101/2024.01.10.575036.
5
A Phase 1b Adaptive Androgen Deprivation Therapy Trial in Metastatic Castration Sensitive Prostate Cancer.一项针对转移性去势敏感性前列腺癌的1b期适应性雄激素剥夺治疗试验。
Cancers (Basel). 2022 Oct 25;14(21):5225. doi: 10.3390/cancers14215225.
6
Novel evolutionary dynamics of small populations in breast cancer adjuvant and neoadjuvant therapy.乳腺癌辅助和新辅助治疗中小群体的新型进化动力学
NPJ Breast Cancer. 2021 Mar 11;7(1):26. doi: 10.1038/s41523-021-00230-y.
7
The Evolution and Ecology of Resistance in Cancer Therapy.癌症治疗中耐药性的演变和生态学。
Cold Spring Harb Perspect Med. 2020 Nov 2;10(11):a040972. doi: 10.1101/cshperspect.a040972.
8
Integrating evolutionary dynamics into cancer therapy.将进化动力学纳入癌症治疗。
Nat Rev Clin Oncol. 2020 Nov;17(11):675-686. doi: 10.1038/s41571-020-0411-1. Epub 2020 Jul 22.
9
Modeling heterogeneous tumor growth dynamics and cell-cell interactions at single-cell and cell-population resolution.在单细胞和细胞群体分辨率下模拟异质性肿瘤生长动力学和细胞间相互作用。
Curr Opin Syst Biol. 2019 Oct;17:24-34. doi: 10.1016/j.coisb.2019.09.005. Epub 2019 Sep 16.
10
A Secure Occupational Therapy Framework for Monitoring Cancer Patients' Quality of Life.用于监测癌症患者生活质量的安全职业治疗框架。
Sensors (Basel). 2019 Nov 29;19(23):5258. doi: 10.3390/s19235258.

本文引用的文献

1
Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance.基于天然产物的第四代ABC抑制剂的开发:克服癌症多药耐药性的新方法
Anticancer Agents Med Chem. 2015;15(5):605-15. doi: 10.2174/1871520615666150113103439.
2
Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy.是否到了为系统性癌症治疗建立新范例的时候了?一个世纪癌症化疗的经验教训。
Front Pharmacol. 2013 Jun 25;4:68. doi: 10.3389/fphar.2013.00068. eCollection 2013.
3
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.人类胶质母细胞瘤的肿瘤内异质性反映了癌症进化动态。
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4009-14. doi: 10.1073/pnas.1219747110. Epub 2013 Feb 14.
4
P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.P-糖蛋白抑制作为克服癌症多药耐药性的治疗方法:现状和未来展望。
Curr Cancer Drug Targets. 2013 Mar;13(3):326-46. doi: 10.2174/15680096113139990076.
5
Clonal competition with alternating dominance in multiple myeloma.多发性骨髓瘤中具有交替优势的克隆竞争。
Blood. 2012 Aug 2;120(5):1067-76. doi: 10.1182/blood-2012-01-405985. Epub 2012 Apr 12.
6
Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?扩散加权磁共振成像和增强磁共振成像能否准确评估和预测乳腺癌患者新辅助化疗的病理反应?
Breast Cancer Res Treat. 2012 Aug;135(1):17-28. doi: 10.1007/s10549-012-2033-5. Epub 2012 Apr 4.
7
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.多区域测序揭示的肿瘤内异质性和分支进化。
N Engl J Med. 2012 Mar 8;366(10):883-892. doi: 10.1056/NEJMoa1113205.
8
Clonal evolution in cancer.癌症中的克隆进化。
Nature. 2012 Jan 18;481(7381):306-13. doi: 10.1038/nature10762.
9
Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research.忽视进化:癌症复发和治疗抵抗研究的系统分析。
PLoS One. 2011;6(11):e26100. doi: 10.1371/journal.pone.0026100. Epub 2011 Nov 17.
10
Drug resistance and cellular adaptation to tumor acidic pH microenvironment.耐药性和细胞对肿瘤酸性 pH 微环境的适应。
Mol Pharm. 2011 Dec 5;8(6):2032-8. doi: 10.1021/mp200292c. Epub 2011 Oct 26.